Home > Insider Trading > Filing (0001181431-13-003277)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1429260	Coronado Biosciences Inc	CNDO	Pharmaceutical Preparations (2834)	205157386

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1555563	F Harlan Weisman	C/O Coronado Biosciences, Inc. 24 New England Executive Park Burlington MA 01803	Chairman And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-01-14	20,000	$5.71	20,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Options to purchase Common Stock	$5.72		2022-08-16	25,000	25,000	Direct
Common Stock	Options to purchase Common Stock	$5.57		2023-01-07	1,686,590	1,686,590	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2022-08-16	25,000	25,000	Direct
2023-01-07	1,686,590	1,686,590	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.63 to $5.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
One-third of the shares will vest on each of August 16, 2013, 2014 and 2015.
One-third of the shares will vest on each of December 28, 2013, 2014 and 2015, subject to Dr. Weisman's continued employment with the Issuer.